Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/13/2008 | US20080279871 Immunogenic composition |
11/13/2008 | US20080279870 ALK protein tyrosine kinase, cells and methods embodying and using same |
11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
11/13/2008 | US20080279859 Neurite outgrowth inhibitor -66 receptor (NOGO-66) specific monoclonal antibody for treatment and prevention of nervous system, muscular, tumor and vision disorders |
11/13/2008 | US20080279857 Therapeutic Agent |
11/13/2008 | US20080279855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions |
11/13/2008 | US20080279854 Tumor suppressor antigen (5T4) for use as therapeutic tool in treatment and prevention of cell proliferative disorders |
11/13/2008 | US20080279852 Methods of treatment with glycosylated antibodies |
11/13/2008 | US20080279850 Tetraspanin specific immunoglobulin for use in the treatment and prevention of non-burkitt's malignancy |
11/13/2008 | US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
11/13/2008 | US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof |
11/13/2008 | US20080279838 Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates |
11/13/2008 | US20080279823 Modified cytokine for use in tredatment and prevention of autoimmune, cell proliferative targeting and infectious disorders |
11/13/2008 | US20080279785 Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications |
11/13/2008 | US20080277080 Overexpression and repression of genes in plants; myo-inositol 1-phosphate synthase, myo-inositol monophosphatase, myo-inositol oxygenase, beta -glucuronidase, glucuronokinase, glucuronosyltransferase, glucuronate-1-phosphate uridyltransferase, phosphoglucomutase, UDP-glucose pyrophosphorylase and more |
11/13/2008 | CA2723320A1 Il-12 immunotherapy for cancer |
11/13/2008 | CA2720634A1 Nuclear conditional male sterility system in brassica napus and its use for producing male fertile hybrid seed of brassica napus |
11/13/2008 | CA2692815A1 Hcv gene |
11/13/2008 | CA2690561A1 New hybrid system for brassica napus |
11/13/2008 | CA2689535A1 Viral vector and use thereof |
11/13/2008 | CA2687395A1 Complement factor h-derived short consensus repeat-antibody constructs |
11/13/2008 | CA2686735A1 Amino acid lipids and uses thereof |
11/13/2008 | CA2686398A1 Two-component genome flavivirus and uses thereof |
11/13/2008 | CA2686263A1 Expression system used for the antibiotic-free production of polypeptides |
11/13/2008 | CA2685840A1 Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis |
11/13/2008 | CA2685453A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
11/13/2008 | CA2685417A1 Viral vector for gene therapy |
11/13/2008 | CA2685252A1 Methods for assessing the delivery of small inhibitory rna molecules |
11/13/2008 | CA2685223A1 Plants having enhanced yield-related traits and a method for making the same |
11/13/2008 | CA2684928A1 A method for production of moth orchid having modified flower color |
11/13/2008 | CA2684923A1 Dna plasmids having improved expression and stability |
11/13/2008 | CA2684719A1 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
11/13/2008 | CA2684703A1 Bicyclic compound and pharmaceutical use thereof |
11/13/2008 | CA2666179A1 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
11/12/2008 | EP1990428A1 Nucleic acid detection methods using universal priming |
11/12/2008 | EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
11/12/2008 | EP1990418A1 Oncolytic adenoviruses for the treatment of cancer |
11/12/2008 | EP1990417A1 Archaeal plasmid vector system |
11/12/2008 | EP1990416A1 Method for production of l-amino acid |
11/12/2008 | EP1990415A1 Osteoprotegerin |
11/12/2008 | EP1990414A1 Means for treating inflammatory diseases, autoimmune diseases and cancer |
11/12/2008 | EP1990413A1 Screening method for candidate drugs |
11/12/2008 | EP1990412A2 Promoters |
11/12/2008 | EP1990411A1 Method of organism identification by dna tag |
11/12/2008 | EP1990410A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND |
11/12/2008 | EP1990409A2 Bacteriophage |
11/12/2008 | EP1990408A1 Scleral cell strain |
11/12/2008 | EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment |
11/12/2008 | EP1990056A1 Tooth root formation promoter and method for promotion of tooth root formation |
11/12/2008 | EP1990040A1 Nanoparticle delivery vehicle |
11/12/2008 | EP1989939A1 Oasis gene-deficient mouse |
11/12/2008 | EP1989330A2 Alpha-synuclein kinase |
11/12/2008 | EP1989328A2 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome |
11/12/2008 | EP1989317A2 Method and apparatus for avalanche-mediated transfer of agents into cells |
11/12/2008 | EP1989316A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
11/12/2008 | EP1989315A2 Generation of marker-free and backbone-free transgenic plants using a single binary approach |
11/12/2008 | EP1989314A2 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use |
11/12/2008 | EP1989313A2 Transgenic brinjal (solanum melongena) expressing the cryiac gene |
11/12/2008 | EP1989312A1 Use of trehalose-6-phosphate synthase to modulate plant growth |
11/12/2008 | EP1989311A2 Stomatal guard cell specific promoter |
11/12/2008 | EP1989310A2 System for producing aromatic molecules by bioconversion |
11/12/2008 | EP1989309A2 Genetic modification of homolactic thermophilic bacilli |
11/12/2008 | EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
11/12/2008 | EP1989307A2 NOVEL TANDEM siRNAS |
11/12/2008 | EP1989306A1 Plant egg cell transcriptional control sequences |
11/12/2008 | EP1989305A2 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma |
11/12/2008 | EP1989299A2 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof |
11/12/2008 | EP1989230A2 Anti-fgf19 antibodies and methods using same |
11/12/2008 | EP1989224A2 Immunogenic peptides and methods of use |
11/12/2008 | EP1989222A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
11/12/2008 | EP1988926A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
11/12/2008 | EP1937817A4 Compositions and methods for modulating pigment production in plants |
11/12/2008 | EP1841864A4 Charge neutralization of polyion complexes |
11/12/2008 | EP1799709A4 Myostatin isoform |
11/12/2008 | EP1797186A4 Expression system, components thereof and methods of use |
11/12/2008 | EP1740700B1 Exo-endo cellulase fusion protein |
11/12/2008 | EP1727826A4 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
11/12/2008 | EP1692270B1 A microorganism producing 5 -xanthylic acid |
11/12/2008 | EP1682582A4 Method for the mass production of immunoglobulin constant region |
11/12/2008 | EP1664094B1 Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps |
11/12/2008 | EP1648909A4 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
11/12/2008 | EP1639011B1 Pegylated single domain antibodies (dAb) |
11/12/2008 | EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
11/12/2008 | EP1478738B1 Anti-ccr5 antibody |
11/12/2008 | EP1478659B1 Biologically active peptides |
11/12/2008 | EP1469010B1 Transcription regulatory gene and peptide |
11/12/2008 | EP1465912B1 Chimeric tnf ligands |
11/12/2008 | EP1462524B1 Cellulase preparations containing reducing agent and method of processing fiber |
11/12/2008 | EP1448581B1 Methods for detection and quantification of analytes in complex mixtures |
11/12/2008 | EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis |
11/12/2008 | EP1440155B1 Lipase variants |
11/12/2008 | EP1436414B1 Detection of rpob sequences of mycobacterium tuberculosis |
11/12/2008 | EP1432729B1 Peyers's patch and/or m-cell targeting ligands |
11/12/2008 | EP1424894B1 Inhibition of pathological angiogenesis in vivo |
11/12/2008 | EP1414994B9 Vaccinia virus for diagnosis and therapy of tumors |
11/12/2008 | EP1404811B1 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
11/12/2008 | EP1392831B1 Moraxella(branhamella) catarrhalis antigens |
11/12/2008 | EP1352086B1 Polynucleotide probes for detection and quantitation of candida species |
11/12/2008 | EP1259615B1 Antibodies against eotaxin and their use |
11/12/2008 | EP1234046B1 Udp-glucose:aglycon-glucosyltransferase |